196 related articles for article (PubMed ID: 29804151)
21. Design, Synthesis, In Vitro Anti-cancer Activity, ADMET Profile and Molecular Docking of Novel Triazolo[3,4-a]phthalazine Derivatives Targeting VEGFR-2 Enzyme.
El-Helby AA; Sakr H; Ayyad RRA; El-Adl K; Ali MM; Khedr F
Anticancer Agents Med Chem; 2018; 18(8):1184-1196. PubMed ID: 29651967
[TBL] [Abstract][Full Text] [Related]
22. Synthesis, Characterization, Antibacterial and Antioxidant Potency of NSubstituted- 2-Sulfanylidene-1,3-Thiazolidin-4-one Derivatives and QSAR Study.
Brahmbhatt H; Molnar M; Pavić V; Rastija V
Med Chem; 2019; 15(8):840-849. PubMed ID: 30520381
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and antimycobacterial evaluation of novel Phthalazin-4-ylacetamides against log- and starved phase cultures.
Sriram D; Yogeeswari P; Senthilkumar P; Sangaraju D; Nelli R; Banerjee D; Bhat P; Manjashetty TH
Chem Biol Drug Des; 2010 Apr; 75(4):381-91. PubMed ID: 20148903
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and characterization of new N-(4-(4-chloro-1H-imidazol-1-yl)-3-methoxyphenyl)amide/sulfonamide derivatives as possible antimicrobial and antitubercular agents.
Ranjith PK; Pakkath R; Haridas KR; Kumari SN
Eur J Med Chem; 2014 Jan; 71():354-65. PubMed ID: 24361479
[TBL] [Abstract][Full Text] [Related]
25. Identification of a novel inhibitor of isocitrate lyase as a potent antitubercular agent against both active and non-replicating Mycobacterium tuberculosis.
Liu Y; Zhou S; Deng Q; Li X; Meng J; Guan Y; Li C; Xiao C
Tuberculosis (Edinb); 2016 Mar; 97():38-46. PubMed ID: 26980494
[TBL] [Abstract][Full Text] [Related]
26. Novel isoniazid embedded triazole derivatives: Synthesis, antitubercular and antimicrobial activity evaluation.
Patil PS; Kasare SL; Haval NB; Khedkar VM; Dixit PP; Rekha EM; Sriram D; Haval KP
Bioorg Med Chem Lett; 2020 Oct; 30(19):127434. PubMed ID: 32717369
[TBL] [Abstract][Full Text] [Related]
27. New Approaches for the Synthesis of Heterocyclic Compounds Corporating Benzo[d]imidazole as Anticancer Agents, Tyrosine, Pim-1 Kinases Inhibitions and their PAINS Evaluations.
Mohareb RM; Milad YR; Mostafa BM; El-Ansary RA
Anticancer Agents Med Chem; 2021; 21(3):327-342. PubMed ID: 32698742
[TBL] [Abstract][Full Text] [Related]
28. Design, synthesis and evaluation of novel indole-2-carboxamides for growth inhibition of
Alsayed SSR; Lun S; Bailey AW; Suri A; Huang CC; Mocerino M; Payne A; Sredni ST; Bishai WR; Gunosewoyo H
RSC Adv; 2021 Apr; 11(26):15497-15511. PubMed ID: 35481189
[TBL] [Abstract][Full Text] [Related]
29. Synthesis of 2-(6-substituted quinolin-4-yl)-1-alkoxypropan-2-ol as potential antimycobacterial agents.
Shinde A; Thakare PP; Nandurkar Y; Chavan A; Shaikh ALN; Mhaske PC
Chem Zvesti; 2023; 77(7):3791-3802. PubMed ID: 37252671
[TBL] [Abstract][Full Text] [Related]
30. Dihydrobenzothiazole coupled N-piperazinyl acetamides as antimicrobial agents: Design, synthesis, biological evaluation and molecular docking studies.
Bollikanda RK; Nagineni D; Pranathi AN; Chirra N; Misra S; Kantevari S
Arch Pharm (Weinheim); 2024 Feb; 357(2):e2300450. PubMed ID: 38036302
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and Antibacterial Activity of Mefloquine-Based Analogs Against Sensitive and Resistant Mycobacterium tuberculosis Strains.
da Silva Araújo A; Moraes AM; Lourenço MCS; Pessoa CO; da Silva ET; de Souza MVN
Curr Top Med Chem; 2019; 19(9):683-689. PubMed ID: 30836914
[TBL] [Abstract][Full Text] [Related]
32. Design, synthesis, bio-evaluation, and
Pham EC; Thi Le TV; Truong TN
RSC Adv; 2022 Jul; 12(33):21621-21646. PubMed ID: 35975065
[TBL] [Abstract][Full Text] [Related]
33. Synthesis of some novel 2-substituted-5-[isopropylthiazole] clubbed 1,2,4-triazole and 1,3,4-oxadiazoles as potential antimicrobial and antitubercular agents.
Suresh Kumar GV; Rajendraprasad Y; Mallikarjuna BP; Chandrashekar SM; Kistayya C
Eur J Med Chem; 2010 May; 45(5):2063-74. PubMed ID: 20149496
[TBL] [Abstract][Full Text] [Related]
34. Design, synthesis and biological evaluation of benzo-[
Chitti S; Van Calster K; Cappoen D; Nandikolla A; Khetmalis YM; Cos P; Kumar BK; Murugesan S; Gowri Chandra Sekhar KV
RSC Adv; 2022 Aug; 12(35):22385-22401. PubMed ID: 36105967
[TBL] [Abstract][Full Text] [Related]
35. Assessing p-tolyloxy-1,3,4-oxadiazole acetamides as lipoxygenase inhibitors assisted by in vitro and in silico studies.
Bashir B; Riaz N; Abida Ejaz S; Saleem M; Ashraf M; Iqbal A; Muzaffar S; Ejaz S; Aziz-Ur-Rehman ; Mohammad Kashif Mahmood H; Bhattarai K
Bioorg Chem; 2022 Dec; 129():106144. PubMed ID: 36116325
[TBL] [Abstract][Full Text] [Related]
36. Development of 3-phenyl-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine derivatives as novel Mycobacterium tuberculosis pantothenate synthetase inhibitors.
Samala G; Devi PB; Nallangi R; Yogeeswari P; Sriram D
Eur J Med Chem; 2013 Nov; 69():356-64. PubMed ID: 24077526
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and biological evaluation of some novel polysubstituted pyrimidine derivatives as potential antimicrobial and anticancer agents.
Rostom SA; Ashour HM; Abd El Razik HA
Arch Pharm (Weinheim); 2009 May; 342(5):299-310. PubMed ID: 19415663
[TBL] [Abstract][Full Text] [Related]
38. Design and synthesis of benzimidazole analogs endowed with oxadiazole as selective COX-2 inhibitor.
Rathore A; Rahman MU; Siddiqui AA; Ali A; Shaharyar M
Arch Pharm (Weinheim); 2014 Dec; 347(12):923-35. PubMed ID: 25303727
[TBL] [Abstract][Full Text] [Related]
39. Investigation of new 1,2,3-triazolyl-quinolinyl-propan-2-ol derivatives as potential antimicrobial agents:
Shinde AD; Nandurkar YM; Bhalekar S; Walunj YS; Ugale S; Ahmad I; Patel H; Chavan AP; Mhaske PC
J Biomol Struct Dyn; 2024; 42(3):1191-1207. PubMed ID: 37254438
[TBL] [Abstract][Full Text] [Related]
40. Novel Pyrazolo[3,4-b]pyridine Derivatives: Synthesis, Characterization, Antimicrobial and Antiproliferative Profile.
Salem MS; Ali MA
Biol Pharm Bull; 2016; 39(4):473-83. PubMed ID: 27040621
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
